NPM1 Gene

Last updated on: 29.10.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

NPM1 (NPM1 is the acronym for "Nucleophosmin 1") is a protein-coding gene located on chromosome 5q35.1. The protein encoded by this gene is involved in several cellular processes, including centrosome duplication, protein chaperoning, and cell proliferation. The encoded phosphoprotein shuttles between the nucleolus, nucleus and cytoplasm and chaperones ribosomal proteins and nuclear histones from the nucleus to the cytoplasm. Nucleophosmin 1 sequesters the tumor suppressor ARF in the nucleolus and protects it from degradation until it is needed.

General informationThis section has been translated automatically.

Diseases associated with NPM1 include Acute Myeloid Leukemia. Related pathways include cell cycle, mitosis, and HIF-1-alpha transcription factor network. An important paralog of this gene is NPM2.

AML with mutated NPM1 is a provisional entity in the WHO classification of AML. FLT3 mutations should be investigated in parallel in AML as they have prognostic implications. NPM1 mutations in exon 12 in the absence of FLT3 ITD are associated with a good prognosis.

LiteratureThis section has been translated automatically.

  1. Falini B et al (2020) NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood 136:1707-1721
  2. Heath EM et al (2017) Biological and clinical consequences of NPM1 mutations in AML. Leukemia 31:798-807
  3. Patel SS et al (2020) NPM1 Biology in Myeloid Neoplasia. Curr Hematol Malig Rep 15:350-359.

Last updated on: 29.10.2021